Juan Estévez-Gallego

Juan Estévez-Gallego

Auto-generated profile, based on publicly available information

Juan Estévez-Gallego

Centro de Investigaciones Biológicas (CIB,CSIC), Ramiro de Maeztu 9, 28040, Madrid, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2020 in eLife
Verified
Journal Article
Open access
JEJuan Estévez-Gallego
Juan Estévez-Gallego
FPFernando Josa Prado
Fernando Josa Prado
SKSiou Ku
Siou Ku
Rubén M. BueyRubén M. Buey
Rubén M. Buey
FBFrancisco A Balaguer
Francisco A Balaguer
MOMaría A. Oliva
María A. Oliva
Microtubules (MTs) are hollow cylinders made of tubulin, a GTPase responsible for essential functions during cell growth and division, and thus, key target for anti-tumor drugs. In MTs, GTP hydrolysis triggers structural changes in the lattice, which are responsible for interaction with regulatory factors. The stabilizing GTP-cap is a hallmark of MTs and the mechanism of the chemical-structural link between the GTP hydrolysis site and the MT lattice is a matter of debate. We have analyzed the structure of tubulin and MTs assembled in the presence of fluoride salts that mimic the GTP-bound and GDP•Pi transition states. Our results challenge current models because tubulin does not change axial length upon GTP hydrolysis. Moreover, analysis of the structure of MTs assembled in the presence of several nucleotide analogues and of taxol allows us to propose that previously described lattice expansion could be a post-hydrolysis stage involved in Pi release.

9 December 2019 in Nature Materials
Verified
Journal Article
Closed access
PDF file
ARAnkit Rai
Ankit Rai
TLTianyang Liu
Tianyang Liu
SGSimon Glauser
Simon Glauser
EKEugene A. Katrukha
Eugene A. Katrukha
JEJuan Estévez-Gallego
Juan Estévez-Gallego
AAAnna Akhmanova
Anna Akhmanova

9 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OBOskía Bueno
Oskía Bueno
JGJuan Estévez Gallego
Juan Estévez Gallego
SMSolange Martins
Solange Martins
APAndrea E. Prota
Andrea E. Prota
FGFederico Gago
Federico Gago
EPEva María Priego
Eva María Priego
Microtubule-targeting agents that bind at the colchicine-site of tubulin are of particular interest in antitumoral therapy due to their dual mechanism of action as antimitotics and vascular disrupting agents. Cyclohexanediones derivatives have been described as a new family of colchicine-domain binders with an association constant to tubulin similar to that of colchicine. Here, the high-resolution structures of tubulin in complex with cyclohexanediones TUB015 and TUB075 were solved by X-ray crystallography. A detailed analysis of the tubulin-TUB075 interaction by means of computational affinity maps allowed the identification of two additional regions at the binding site that were addressed with the design and synthesis of a new series of cyclohexanediones with a distal 2-substituted benzofurane. These new compounds showed potent antiproliferative activity with IC50 values in the nM range, arrested cell cycle progression at the G2/M phase and induced apoptosis at sub μM concentrations. Moreover, they caused the destruction of a preformed vascular network in vitro and inhibited the migration of endothelial cells at non-toxic concentrations. Finally, these compounds displayed high affinity for tubulin as substantiated by a K b value of 2.87 × 108 M−1 which, to the best of our knowledge, represents the highest binding constant measured to date for a colchicine-domain ligand.

Verified
Journal Article
Open access
PDF file
FBFrancisco de Asís Balaguer
Francisco de Asís Balaguer
TMTobias Mühlethaler
Tobias Mühlethaler
JEJuan Estévez-Gallego
Juan Estévez-Gallego
ECEnrique Calvo
Enrique Calvo
JAJuan Giménez Abián
Juan Giménez Abián
JJosé Fernando Díaz
José Fernando Díaz
It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.

12 October 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
JFJessica J. Field
Jessica J. Field
BPBenet Pera
Benet Pera
JGJuan Estévez Gallego
Juan Estévez Gallego
ECEnrique Calvo
Enrique Calvo
JRJavier Rodríguez-Salarichs
Javier Rodríguez-Salarichs
JJosé Fernando Díaz
José Fernando Díaz

1 March 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
OBOskía Bueno
Oskía Bueno
GTGloria Tobajas
Gloria Tobajas
EQErnesto Quesada
Ernesto Quesada
JEJuan Estévez-Gallego
Juan Estévez-Gallego
SNSam Noppen
Sam Noppen
María-Jesús Pérez-PérezMaría-Jesús Pérez-Pérez
María-Jesús Pérez-Pérez